Adaptimmune Email Format

Biotechnology Research
201-500 employees
Abingdon, Oxfordshire, UK

Adaptimmune is a fully integrated cell therapy company specializing in preclinical research, clinical development, and autologous and allogeneic manufacturing across UK and US biotechnology hubs.

Find contacts at Adaptimmune

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@adaptimmune.com

Company Overview

Industry
Biotechnology Research
Founded
2008
Headquarters
Abingdon, Oxfordshire, UK
Revenue
$250M-$500M
FUNDING Stage
Public
Key Executives
Christopher Hill (Chief Executive Officer)

Tech Stack

Amazon Web Services

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Adaptimmune?

Adaptimmune uses the first.last format on adaptimmune.com, so Jane Smith would be jane.smith@adaptimmune.com.

What cancer type is Adaptimmune's approved therapy Tecelra designed to treat?

Tecelra (afamitresgene autoleucel) received FDA accelerated approval in August 2024 for adults with unresectable or metastatic synovial sarcoma, making it the first engineered T-cell therapy approved for a solid tumor in the United States.

How does Adaptimmune's SPEAR T-cell technology work?

Adaptimmune's SPEAR T-cell platform engineers a patient's T-cell receptors to recognize and attack specific cancer proteins, allowing the modified cells to target solid tumors that have historically been difficult to treat with standard cell therapies.

Where does Adaptimmune have offices?

Adaptimmune is headquartered in Abingdon, Oxfordshire, UK, and also has a significant U.S. presence in Philadelphia at the Navy Yard. If you need to reach a specific contact at either location, a tool like Clay can help verify the right person and email address.

Who is the CEO of Adaptimmune?

Christopher Hill serves as Chief Executive Officer of Adaptimmune. The company, founded in 2008, is a biopharmaceutical firm focused on developing TCR-based T-cell therapies for cancer patients.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles